Nora Cazzagon

5.5k total citations · 1 hit paper
69 papers, 2.2k citations indexed

About

Nora Cazzagon is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Nora Cazzagon has authored 69 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hepatology, 50 papers in Epidemiology and 19 papers in Surgery. Recurrent topics in Nora Cazzagon's work include Liver Diseases and Immunity (55 papers), Liver Disease Diagnosis and Treatment (47 papers) and Gallbladder and Bile Duct Disorders (18 papers). Nora Cazzagon is often cited by papers focused on Liver Diseases and Immunity (55 papers), Liver Disease Diagnosis and Treatment (47 papers) and Gallbladder and Bile Duct Disorders (18 papers). Nora Cazzagon collaborates with scholars based in Italy, France and United States. Nora Cazzagon's co-authors include Annarosa Floreani, Mireen Friedrich‐Rust, Annalisa Berzigotti, Laurent Castéra, Salvatore Petta, Emmanuel Tsochatzis, Jérôme Boursier, Maja Thiele, I. Franceschet and Vincenzo Baldo and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Nora Cazzagon

63 papers receiving 2.2k citations

Hit Papers

EASL Clinical Practice Guidelines on non-invasive tests f... 2021 2026 2022 2024 2021 250 500 750

Peers

Nora Cazzagon
Imran Patanwala United Kingdom
Ahmad H. Ali United States
F. Rosina Italy
Lisa Forman United States
David E.J. Jones United Kingdom
Nora Cazzagon
Citations per year, relative to Nora Cazzagon Nora Cazzagon (= 1×) peers Oreste Lo Iacono

Countries citing papers authored by Nora Cazzagon

Since Specialization
Citations

This map shows the geographic impact of Nora Cazzagon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Cazzagon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Cazzagon more than expected).

Fields of papers citing papers by Nora Cazzagon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Cazzagon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Cazzagon. The network helps show where Nora Cazzagon may publish in the future.

Co-authorship network of co-authors of Nora Cazzagon

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Cazzagon. A scholar is included among the top collaborators of Nora Cazzagon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Cazzagon. Nora Cazzagon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holmer, Magnus, Michael Ingre, Martti Färkkilâ, et al.. (2025). Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study. Hepatology. 83(1). 21–29.
2.
Zingone, Fabiana, Cristina Canova, Anders Forss, et al.. (2025). Prevalence of Celiac Disease in Patients With Primary Biliary Cholangitis: A Systematic Review and Meta‐Analysis. Liver International. 45(9). e70293–e70293.
3.
Ferrarese, Alberto, Nora Cazzagon, & Patrizia Burra. (2024). Liver transplantation for Wilson disease: Current knowledge and future perspectives. Liver Transplantation. 30(12). 1289–1303. 2 indexed citations
4.
Gringeri, Enrico, Nora Cazzagon, Annarosa Floreani, et al.. (2024). Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data. Journal of Personalized Medicine. 14(3). 222–222. 2 indexed citations
5.
Cazzagon, Nora, et al.. (2024). Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship. Minerva Gastroenterology. 71(1). 33–47. 1 indexed citations
6.
Cazzagon, Nora, S. El Mouhadi, Carlos Ferreira, et al.. (2022). Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis. JHEP Reports. 4(11). 100577–100577. 15 indexed citations
7.
Floreani, Annarosa, B. Coco, Edoardo G. Giannini, et al.. (2022). Primary biliary cholangitis: perception and expectation of illness. Digestive and Liver Disease. 54(9). 1230–1233. 2 indexed citations
8.
Cossiga, Valentina, Nora Cazzagon, Roberto Montalti, et al.. (2022). The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight. Digestive and Liver Disease. 55(6). 778–784. 1 indexed citations
9.
Goet, Jorn, Annarosa Floreani, Xavier Verhelst, et al.. (2019). Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis. Journal of Hepatology. 71(5). 992–999. 27 indexed citations
10.
Cazzagon, Nora, Olivier Chazouillères, Christophe Corpechot, et al.. (2019). Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology. 43(4). 387–394. 7 indexed citations
11.
Arrivé, Lionel, et al.. (2019). Non-contrast MR lymphography of the lymphatic system of the liver. European Radiology. 29(11). 5879–5888. 13 indexed citations
12.
Floreani, Annarosa, Ying Sun, Baosen Li, et al.. (2015). Proposed therapies in primary biliary cholangitis. Expert Review of Gastroenterology & Hepatology. 10(3). 371–382. 10 indexed citations
13.
Floreani, Annarosa, Raffaella Motta, Nora Cazzagon, et al.. (2015). The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. Digestive and Liver Disease. 47(5). 432–435. 18 indexed citations
14.
Floreani, Annarosa, I. Franceschet, Nora Cazzagon, et al.. (2014). Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis. Clinical Reviews in Allergy & Immunology. 48(2-3). 192–197. 113 indexed citations
15.
Floreani, Annarosa, et al.. (2013). Metabolic Syndrome Associated With Primary Biliary Cirrhosis. Journal of Clinical Gastroenterology. 49(1). 57–60. 29 indexed citations
16.
Giacomin, Anna, et al.. (2012). Molecular Targeted Therapy in Hepatocellular Carcinoma: Present Achievements and Future Challenges. Digestive Diseases. 30(3). 284–288. 4 indexed citations
17.
Antoniazzi, Sara, et al.. (2011). 1285 THE OUTCOME OF PREGNANCY IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS. Journal of Hepatology. 54. S507–S507. 1 indexed citations
18.
Farinati, Fabio, Anna Giacomin, A. Sérgio, et al.. (2011). Liver transplantation for hepatocellular carcinoma in clinical practice. European Journal of Gastroenterology & Hepatology. 24(2). 195–202. 13 indexed citations
19.
Betterle, Corrado, Daniela Basso, Claudia Mescoli, et al.. (2011). Gastric type I carcinoid: a pilot study with human G17DT immunogen vaccination. Cancer Immunology Immunotherapy. 60(7). 1057–1060. 9 indexed citations
20.
Floreani, Annarosa, D. Caroli, Angela Variola, et al.. (2010). A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Liver International. 31(3). 361–368. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026